Pancreatic neuroendocrine tumors: Overview of recent advances and diagnosis

Journal of Gastrointestinal Surgery

Volumn 10, Issue 3, 2006, Pages 324-326

  Jensen, Robert T ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33644547723     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gassur.2005.08.022     Document Type: Editorial

References (29)

1. R.A. Alexander, and R.T. Jensen Pancreatic endocrine tumors V.T. DeVita S. Hellman S.A. Rosenberg Cancer: Principles and Practice of Oncology 2001 Lippincott Williams & Wilkins Philadelphia 1788 1813
2. J.C. Mansour, and H. Chen Pancreatic endocrine tumors J Surg Res 120 2004 139 160
3. R.T. Jensen Natural history of digestive endocrine tumors M. Mignon J.F. Colombel Recent Advances in Pathophysiology and Management of Inflammatory Bowel Diseases and Digestive Endocrine Tumors 1999 John Libbey Eurotext Paris 192 219
4. V.D. Corleto, G. Delle Fave, and R.T. Jensen Molecular insights into gastrointestinal NE tumors: importance and recent advances Dig Liver Dis 34 2002 668 680
5. R.T. Jensen Endocrine tumors of the pancreas T. Yamada D.H. Alpers N. Kaplowitz Textbook of Gastroenterology 2003 Lippincott Williams and Wilkins Philadelphia 2108 2146
6. D. Kwekkeboom, E.P. Krenning, and M. deJong Peptide receptor imaging and therapy J Nucl Med 41 2000 1704 1713
7. F. Gibril, M. Schumann, and A. Pace Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome. A prospective study of 107 cases and comparison with 1009 patients from the literature Medicine 83 2004 43 83
8. J.A. Norton, and R.T. Jensen Resolved and unresolved controversies in the surgical management of patients with Zollinger-Ellison syndrome Ann Surg 240 2004 757 773
9. A.A. Gumbs, P.S. Moore, and M. Falconi Review of the clinical, histological, and molecular aspects of pancreatic endocrine neoplasms J Surg Oncol 81 2002 45 53
10. F. Gibril, and R.T. Jensen Zollinger-Ellison syndrome revisited: diagnosis, biologic markers, associated inherited disorders, and acid hypersecretion Curr Gastroenterol Rep 6 2004 454 463
11. P. Roy, D.J. Venzon, and H. Shojamanesh Zollinger-Ellison syndrome: clinical presentation in 261 patients Medicine 79 2000 379 411
12. V.D. Corleto, B. Annibale, and F. Gibril Does the widespread use of proton pump inhibitors mask, complicate and/or delay the diagnosis of Zollinger-Ellison syndrome? Aliment Pharmacol Ther 15 2001 1555 1561
13. H.C. Weber, D.J. Venzon, and J.T. Lin Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study Gastroenterology 108 1995 1637 1649
14. F. Yu, D.J. Venzon, and J. Serrano Prospective study of the clinical course, prognostic factors and survival in patients with longstanding Zollinger-Ellison syndrome J Clin Oncol 17 1999 615 630
15. I. Madeira, B. Terris, and M. Voss Prognostic factors in patients with endocrine tumours of the duodenopancreatic area Gut 43 1998 422 427
16. V.E. Sutliff, J.L. Doppman, and F. Gibril Growth of newly diagnosed, untreated metastatic gastrinomas and predictors of growth patterns J Clin Oncol 15 1997 2420 2431
17. R.T. Jensen Zollinger-Ellison syndrome G.M. Doherty B. Skogseid Surgical Endocrinology: Clinical Syndromes 2001 Lippincott Williams & Wilkins Philadelphia 291 344
18. A.C. Berger, F. Gibril, and D.J. Venzon Prognostic value of initial fasting serum gastrin level in patients with Zollinger-Ellison syndrome J Clin Oncol 19 2001 3051 3057
19. N.W. Thompson Current concepts in the surgical management of multiple endocrine neoplasia type 1 pancreatic-duodenal disease. Results in the treatment of 40 patients with Zollinger-Ellison syndrome, hypoglycemia or both J Intern Med 243 1998 495 500
20. L. Gullo, M. Migliori, and M. Falconi Nonfunctioning pancreatic endocrine tumors: a multicenter clinical study Am J Gastroenterol 98 2003 2435 2439
21. P.L. Peghini, M. Iwamoto, and M. Raffeld Overexpression of epidermal growth factor and hepatocyte growth factor receptors in a proportion of gastrinomas correlates with aggressive growth and lower curability Clin Cancer Res 8 2002 2273 2285
22. S.U. Goebel, M. Iwamoto, and M. Raffeld HER-2/neu expression and gene amplification in gastrinomas: correlations with tumor biology, growth, and aggressiveness Cancer Res 62 2002 3702 3710
23. F. Gibril, and R.T. Jensen Diagnostic uses of radiolabelled somatostain-receptor analogues in gastroenteropancreatic endocrine tumors Dig Liver Dis 36 2004 S106 S120
24. O. Schillaci, A. Spanu, and F. Scopinaro Somatostatin receptor scintigraphy with 111 Inpentetreotide in non-functioning gastroenteropancreatic NE tumors Int J Oncol 23 2003 1687 1695
25. F. Gibril, J.C. Reynolds, and J.L. Doppman Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas: a prospective study Ann Intern Med 125 1996 26 34
26. M.A. Anderson, S. Carpenter, and N.W. Thompson Endoscopic ultrasound is highly accurate and directs management in patients with NE tumors of the pancreas Am J Gastroenterol 95 2000 2271 2277
27. A. Sundin, B. Eriksson, and M. Bergstrom PET in the diagnosis of NE tumors Ann N Y Acad Sci 1014 2004 246 257
28. S.U. Goebel, C. Heppner, and A.D. Burns Geneotype/phenotype correlations of MEN1 gene mutations in sporadic gastrinoma J Clin Endocrinol Metab 85 2000 116 123
29. J.A. Norton, D.L. Fraker, and H.R. Alexander Surgery to cure the Zollinger-Ellison syndrome N Engl J Med 341 1999 635 644